Delivery Order SPE2DB22D2009-SPE2DB24FL9NR

Award Date 5/6/24
Potential Completion Date 5/7/24
Potential Value $1.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,563,455,569 units of Duloxetine HCL DR 60 mg capsules to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,313.22 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
This federal contract award is for the delivery of 4,563,226,225 units of Duloxetine HCL DR 60 mg capsules in 90-count packages to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $21,729.29, was awarded on January 3, 2024 to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support...
This federal contract award is for the delivery of 4,562,967,827 units of Duloxetine HCL DR 60 mg capsules to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $1,070.83. It is a delivery order contract with a firm fixed price pricing type. The ultimate completion date is December 4, 2023. This contract is not associated with a set-aside program. AmerisourceBergen Drug Corp is...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,564,603,974 units of Duloxetine HCL DR 60 MG capsules in 90-count packages, with a ceiling value of $9,128.77. The contract has an ultimate completion date of May 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This federal contract award is for the delivery of 4,566,471,827 units of Duloxetine HCL DR 40 mg capsules (30 count) to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 18, 2024, with a ceiling value of $1,067.61. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,172.84, is for the supply of 4,567,278,594 units of Duloxetine HCL DR 60 MG capsules. The award is a Firm Fixed Price delivery order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award is for the delivery of Duloxetine HCL DR 60 mg capsules in quantities of 1,000 to the Defense Logistics Agency (DLA). The contract, valued at $1,754.23, was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm-fixed-price delivery order with a completion date of November 20, 2023. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award is a delivery order valued at $7,510.53 issued to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, by the Defense Logistics Agency (DLA). The contract is for the supply of 4,562,766,402 units of Duloxetine HCl DR 60 mg capsules. The contract is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued at up to $999,999,999 and running through November...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4,566,824,824 units of Duloxetine HCL DR 40 mg capsules, with a ceiling value of $1,046.01. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA, which provides a comprehensive range of pharmaceutical products and...
This federal contract award is for the delivery of 4,565,218,389 units of Duloxetine HCL DR 60 MG capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, awarded to Amerisourcebergen Drug Corp, Corporate Office Division, has a ceiling value of $1,787.52. It is a firm fixed-price delivery order contract with an ultimate completion date of July 23, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to supply...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB24FL9NR
    Delivery Order

This federal contract award is for the delivery of 4,564,513,209 units of Duloxetine HCL DR 60 mg capsules to the Defense Logistics Agency (DLA). The contract, valued at $1,511.56, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on May 6, 2024, with a completion date of May 7, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 5/16/25, 12:22 PM